tradingkey.logo

BUZZ-Amneal Pharma rises; J.P.Morgan upgrades stock, raises PT

ReutersFeb 24, 2025 9:34 AM

U.S. drug developer Amneal Pharmaceuticals AMRX.O rises 4.09% to $8.15 in premarket trading

J.P.Morgan upgrades to "overweight" from "neutral"; lifts PT from $9 to $12, ~42% upside to last close of $7.83

Says co well-positioned for sustainable high single-digit growth, driven by strong portfolio of complex generics and biosimilars

Expects AMRX to outperform peers significantly on successful launch of Crexont, used to treat Parkinson's disease, and AvKARE's (co's independent subsidiary) impressive growth

Stock rated "buy" on avg; median PT is $11 - LSEG

AMRX down 1.13% so far this year, as of Friday's close

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI